PFS24 as a prognostic milestone in patients with newly diagnosed primary CNS lymphoma.

Saved in:
Bibliographic Details
Title: PFS24 as a prognostic milestone in patients with newly diagnosed primary CNS lymphoma.
Authors: Zeremski, Vanja1 (AUTHOR) vanja.zeremski@med.ovgu.de, Haage, Tobias R.1 (AUTHOR), Witte, Hanno M.2 (AUTHOR), Adolph, Louisa3 (AUTHOR), Beer, Sina A.4 (AUTHOR), Behre, Gerhard5 (AUTHOR), Jacobs, Benedikt6 (AUTHOR), Kahl, Christoph7,8 (AUTHOR), Lalayanni, Chrysavgi9 (AUTHOR), Panse, Jens10,11 (AUTHOR), Papageorgiou, Sotirios12 (AUTHOR), Siakantaris, Marina P.13 (AUTHOR), Schneider, Jessica14 (AUTHOR), Schnetzke, Ulf15 (AUTHOR), Schulz, Alexander5 (AUTHOR), Vassilakopoulos, Theodoros P.13 (AUTHOR), Walter, Jeanette10,11 (AUTHOR), Mougiakakos, Dimitrios1 (AUTHOR)
Source: Journal of Hematology & Oncology. 4/24/2025, Vol. 18 Issue 1, p1-4. 4p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17568722
DOI:10.1186/s13045-025-01700-7